CytoDyn Inc.
CYDYNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CYDY. That does not mean none is planned.
Get an email about CYDY's next catalysts
Track CytoDyn (CYDY) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
How CYDY's past catalysts played out
Market Overview
Stock performance and key metrics
Optimized Background Regimen
HIV
PRO 140
HIV-1-infection
PRO 140 (humanized monoclonal antibody to CCR5)
HIV -1 Infection
Leronlimab
Solid Tumor, Adult
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Optimized Background Regimen | Phase 3 | HIV | - | - |
PRO 140 | Phase 3 | HIV-1-infection | - | - |
PRO 140 (humanized monoclonal antibody to CCR5) | Phase 2 | HIV -1 Infection | - | - |
Leronlimab | Phase 2 | Solid Tumor, Adult | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in CytoDyn Inc.'s drug pipeline?β
CatalystAlert tracks 4 drug candidates in CytoDyn Inc.'s (CYDY) pipeline across Phase 3, Phase 2. Its lead program is Optimized Background Regimen (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CytoDyn Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for CytoDyn Inc. (CYDY) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track CYDY biotech catalysts?β
Add CYDY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CytoDyn Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
